Diamyd Medical AB: Diamyd® Phase III Study Approved by Six European Countries

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Today Diamyd Medical (Pink Sheets:DMYDY)(STO:DIAMB) reported that six European countries have approved the initiation of a Phase III study with the Diamyd® diabetes vaccine for type 1 diabetes.